KCNH2 and torsades de pointes: Drugs can have an unopposed Kv11.1 block (e.g., sotalol and dofetilide, which have high TdP risk) or can block Kv11.1 in addition to the blocking of inward currents (ICa-L, INaL), with a lower risk for TdP.